The Intellectual Property & Technology Commercialization Program accelerates the development of laboratory research towards clinical application by identifying and protecting the Center's intellectual property and facilitating business partnerships for technology licensing and commercialization.
If you are interested in browsing a list of technologies available for licensing from National Jewish, please click on the following selection:
- Biotechnologies - by type and application or by title
- Research Tools: Antibodies, Animal models & Transgenic Mice
- Biomedical devices
Featured Technologies
MAGP-2: an extracellular factor shown to have pro-angiogenic properties in vivo
Because of its extracellular nature, MAGP-2 can be easily detected and targeted, for instance by antibody-based technologies.
Cystatin C : an extracellular antagonist of the TGF-beta receptor proven to decrease tumorigenesis in vivo
Cystatin C and derivatives form the basis for drug development aimed at treating cancers or fibrotic/proliferative diseases regulated by TGF-ß.
Investigator:
 William P. Schiemann, PhD
Interests: Cancer Biology; Signal Transduction; Angiogenesis
Awards and Education: Outstanding Junior Faculty Award, National Jewish Medical and Research Center (2004); Postdoctoral Fellow, 1997-2001, Whitehead Institute for Biomedical Research; PhD, 1996, University of Washington
|
National Jewish has close to 150 technologies in its active portfolio and owns 55 active issued U.S. patents plus additional corresponding foreign patents. A list of National Jewish patents, linked to the U.S. Patent Office web site, is available here.
The Intellectual Property and Technology Commercialization Program is also responsible for:
- Licensing non-patented biological materials developed in National Jewish laboratories
- Review, negotiation, and approval of Materials Transfer Agreements
- Approval for use of National Jewish copyrighted materials
- Management and licensing, where appropriate, of National Jewish trademarks and copyrights
Staff:
Our Address:
National Jewish Medical and Research Center
Intellectual Property and Technology Commercialization
1400 Jackson St.
Denver, CO 80206
Facsimile: 303-270-2352
